Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 7, 2007, Pages 2672-2679

  Masuyama, Hisashi ^a,b   Nakatsukasa, Hideki ^a   Takamoto, Norio ^a   Hiramatsu, Yuji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ENDOGLIN; LEPTIN; PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; GESTATIONAL AGE; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; ONSET AGE; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA;

EID: 34447122605     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-2349     Document Type: Article

References (38)

1. Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC, Hauth JC, Wenstrom KD 2001 Hypertensive disorders in pregnancy. In: Cunningham FG, Williams JW, eds. Williams obstetrics. 21st ed. New York: McGraw-Hill; 568-573
2. Roberts JM, Cooper DW 2001 Pathogenesis and genetics of preeclampsia. Lancet 357:53-56
3. Roberts JM, Lain KY 2002 Recent insights into the pathogenesis of preeclampsia. Placenta 23:359-372
4. Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A 1994 Astudy of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 101:669-674
5. Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR, Torry DS 1997 Vascular endothelial growth factor, placental growth factor and their receptors in isolated human trophoblast. Placenta 18:657-665
6. Polliotti BM, Fry AG, Saller DN, Mooney RA, Cox C, Miller RK 2003 Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early onset preeclampsia. Obstet Gynecol 101:1266-1274
7. Taylor RN, Grimwood J, Taylor RS, McMaster MT, Fisher SJ, North RA 2003 Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathogenic pregnancies. Am J Obstet Gynecol 188:177-182
8. Masuyama H, Suwaki N, Nakatsukasa H, Masumoto A, Tateishi Y, Hiramatrsu Y 2006 Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis. Am J Obstet Gynecol 194:551-556
9. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA 2003 Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111:649-658
10. Koga K, Osuga Y, Yoshino O, Hirota Y, Ruimeng X, Hirata T, Takeda S, Yano T, Tsutsumi O, Taketani Y 2003 Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab 88:2348-2351
11. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA 2004 Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672-683
12. Lebrin F, Deckers M, Bertolino P, Ten Dijke P 2006 TGF-β receptor function in the endothelium. Cardiovasc Res 65:599-608
13. Li C, Hampson IN, Hampson L, Kumar P, Bernabeu C, Kumar S 2000 CD105 antagonizes the inhibitory signaling of transforming growth factor β-1 on human vascular endothelial cells. FASEB J 14:55-64
14. Li C, Issa R, Kumar P, Hampson IN, Lopez-Novoa JM, Bernabeu C, Kumar S CD105 prevents apoptosis in hypoxic endothelial cells. J Cell Sci 116:2677-2685
15. Jekric M, Rivas-Elena JV, Prieto M, Carron R, Sanz-Rodriguez F, Perez-Barriocanal F, Rodríguez-Barbero A, Bernabeú C, López-Novoa JM 2004 Endoglin regulates nitric oxide-dependent vasodilatation. FASEB J 18:609-611
16. Venkatesha S, Toporsian M, Lami C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IS, Roberts D, D'Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA 2006 Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12:642-649
17. Toporsian M, Gros R, Kabir MG, Vera S, Govindaraju K, Eidelman DH, Husain M, Letarte M 2005 A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ Res 96:684-692
18. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA 2006 Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355:992-1005
19. Seely EW, Solomon CG 2003 Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab 88:2393-2398
20. Chou E, Suzuma I, Way KJ, Opland D, Clermont AC, Naruse K, Suzuma, K, Bowling NL, Vlahos CJ, Aiello LP, King GL 2002 Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic states: a possible explanation for impaired collateral formation in cardiac tissue. Circulation 105:373-379
21. Vicent D, Ilany J, Kondo T, Naruse K, Fisher SJ, Kisanuki YY, Bursell, S, Yanagisawa M, King GL, Kahn CR 2003 The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J Clin Invest 111:1373-1380
22. Miele C, Rochford JJ, Filippa N, Giorgetti-Peraldi S, Van Obberghen E 2000 Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways. J Biol Chem 275:21695-21702
23. Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V, Ferrara N 1998 Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 273:30336-30343
24. Gil-Campos M, Canete RR, Gil A 2004 Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 23:963-974
25. Fasshauer M, Paschke R 2003 Regulation of adipocytokines and insulin resistance. Diabetologia 46:1594-1603
26. Inoue M, Yano M, Yamakado M, Maehata E, Suzuki S 2006 Relationship between the adiponectin-leptin ratio and parameters of insulin resistance in subjects without hyperglycemia. Metabolism 55:1248-1254
27. Chaiworapongsa T, Romero R, Espinoza J, Bujold E, Mee Kim Y, Goncalves LF, Gomez R, Edwin S 2004 Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Am J Obstet Gynecol 190:1541-1547
28. Suwaki N, Masuyama H, Nakatsukasa H, Masumoto A, Sumida Y, Takamoto N, Hiramatrsu Y 2006 Hypoadiponectinemia and circulating angiogenic factors in overweight patients complicated with pre-eclampsia. Am J Obstet Gynecol 195:1687-1692
29. Ramsay JE, Jamieson N, Greer IA, Sattar N 2003 Paradoxical elevation in adiponectin concentrations in women with preeclampsia. Hypertension 42:891-894
30. Naruse K, Yamasaki M, Umekage H, Sado H, Sakamoto Y, Morikawa H 2005 Peripheral blood concentrations of adiponectin, an adipocyte-specific plasma protein, in normal pregnancy and preeclampsia. J Reprod Immunol 65:65-75
31. Kajantie E, Kaaja R, Ylikorkala O, Andersson S, Laivuori H 2005 Adiponectin concentrations in maternal serum: elevated in preeclampsia but unrelated to insulin sensitivity. J Soc Gynecol Investig 12:433-439
32. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki, K, Uchida S, Ito Y, Takakuwa K, Matsui J, Takata M, Eto K, Terauchi Y, Komeda K, Tsunoda M, Murakami K, Ohnishi Y, Naitoh T, Yamamura K, Ueyama Y, Froguel P, Kimura S, Nagai, R, Kadowaki T 2003 Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 278:2461-2468
33. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K 2003 Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 14:561-566
34. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, Funahashi T, Matsuzawa Y 2004 Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 94:e27-e31
35. Tan KC, Xu A, Chow WS, Lam MC, Ai VH, Tam SC, Lam KS 2004 Hypoadiponectinaemia is associated with impaired endothelium-dependant vasodilatation. J Clin Endocrinol Metab 89:765-769
36. Shimabukuro M, Higa N, Asahi T, Oshiro Y, Takasu N, Tagawa T, Ueda S, Shimomura I, Funahashi T, Matsuzawa Y 2003 Hypoadiponectinaemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab 88:3236-3240
37. Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, Fu Y, Motone M, Yamamoto K, Matsuo A, Ohashi K, Kihara S, Funahashi T, Rakugi H, Matsuzawa Y, Ogihara T 2004 Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 43:1318-1323
38. Thadhani R, Ecker JL, Mutter WP, Wolf M, Smirnakis KV, Sukhatme VP, Levine RJ, Karumanchi SA 2004 Insulin resistance and alterations in angiogenesis. Hypertension 43:988-992